SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000926617-20-000037
Filing Date
2020-05-14
Accepted
2020-05-14 17:17:20
Documents
38
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vrml-20200331x10q.htm 10-Q 963420
2 EX-31.1 vrml-20200331xex31_1.htm EX-31.1 15394
3 EX-31.2 vrml-20200331xex31_2.htm EX-31.2 15778
4 EX-32.1 vrml-20200331xex32_1.htm EX-32.1 11947
  Complete submission text file 0000926617-20-000037.txt   2958071

Data Files

Seq Description Document Type Size
5 EX-101.INS vrml-20200331.xml EX-101.INS 402335
6 EX-101.SCH vrml-20200331.xsd EX-101.SCH 24639
7 EX-101.CAL vrml-20200331_cal.xml EX-101.CAL 31324
8 EX-101.DEF vrml-20200331_def.xml EX-101.DEF 96788
9 EX-101.LAB vrml-20200331_lab.xml EX-101.LAB 222400
10 EX-101.PRE vrml-20200331_pre.xml EX-101.PRE 188018
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34810 | Film No.: 20878992
SIC: 2835 In Vitro & In Vivo Diagnostic Substances